Carol Sartorius, Ph.D., University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz Medical Campus

Carol Sartorius, Ph.D., University of Colorado Cancer Center

Caption

University of Colorado Cancer Center investigators Carol Sartorius, Ph.D., and Bradley Corr, M.D., show that CK5 marks ovarian cancer likely to resist platinum-based chemotherapies including cisplatin.

Credit

CU Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.